BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33908130)

  • 21. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis.
    Kessler TM; La Framboise D; Trelle S; Fowler CJ; Kiss G; Pannek J; Schurch B; Sievert KD; Engeler DS
    Eur Urol; 2010 Dec; 58(6):865-74. PubMed ID: 20934242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral neuromodulation for lower urinary tract dysfunction and impact on erectile function.
    Lombardi G; Mondaini N; Giubilei G; Macchiarella A; Lecconi F; Del Popolo G
    J Sex Med; 2008 Sep; 5(9):2135-40. PubMed ID: 18637993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sacral neuromodulation: No more skiing?
    Wöllner J; Pannek J
    Scand J Urol; 2016; 50(2):132-3. PubMed ID: 26754577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial Comment: Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dys-function (nLUTD): Over 20 Years' Experience and Fu-ture Directions.
    Averbeck MA
    Int Braz J Urol; 2021; 47(6):1264-1265. PubMed ID: 34469676
    [No Abstract]   [Full Text] [Related]  

  • 26. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease.
    Chen G; Liao L
    Spinal Cord; 2015 Mar; 53(3):204-208. PubMed ID: 25224602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical electrostimulation versus sacral neuromodulation for incomplete spinal cord patients suffering from neurogenic non-obstructive urinary retention.
    Lombardi G; Musco S; Celso M; Ierardi A; Nelli F; Del Corso F; Del Popolo G
    Spinal Cord; 2013 Jul; 51(7):571-8. PubMed ID: 23628893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
    Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation.
    Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G
    Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
    Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
    Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
    Chartier-Kastler E; Le Normand L; Ruffion A; Dargent F; Braguet R; Saussine C; Tanneau Y; Graziana JP; Ragni E; Rabut B; Rousseau T; Biardeau X; Gamé X; Pierrevelcin J; Brassart E; Fourmarier M; Stoica G; Berrogain N; Yaghi N; Pecoux F; Capon G; Ferchaud J; Peyrat L; Bryckaert PE; Karsenty G; Melotti A; Abouihia A; Keller DUJ; Cornu JN
    Eur Urol Focus; 2021 Nov; 7(6):1430-1437. PubMed ID: 32907782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy of sacral neuromodulation in the treatment of voiding dysfunction after endometriosis surgery.
    Aublé A; Gazdovich S; Dégremont S; Pfister C; Roman H; Bridoux V; Leroi AM; Cornu JN
    Prog Urol; 2023 Dec; 33(17):1073-1082. PubMed ID: 37951811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral neuromodulation in congenital lumbo-sacral and traumatic spinal cord defects with neurogenic lower urinary tract symptoms: a single-center experience in children and adolescents.
    Sharifiaghdas F
    World J Urol; 2019 Dec; 37(12):2775-2783. PubMed ID: 30864008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the first rechargeable sacral neuromodulation system for treatment of neurogenic lower urinary tract dysfunction in China: a case report.
    Wang XH; Wang JW; Zhang W; Liu XD; Yan ZH; Meng LF; Zhang YG
    Am J Transl Res; 2023; 15(1):324-329. PubMed ID: 36777833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of sacral neuromodulation in non-neurogenic, non-obstructive dysuria: A 5-year retrospective, multicentre study in China.
    Meng LF; Zhang W; Wang JY; Zhang YG; Zhang P; Liao LM; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
    World J Clin Cases; 2020 Jun; 8(12):2494-2501. PubMed ID: 32607326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation Parameters for Sacral Neuromodulation on Lower Urinary Tract and Bowel Dysfunction-Related Clinical Outcome: A Systematic Review.
    Assmann R; Douven P; Kleijnen J; van Koeveringe GA; Joosten EA; Melenhorst J; Breukink SO
    Neuromodulation; 2020 Dec; 23(8):1082-1093. PubMed ID: 32830414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
    Otto W; Nowrotek A; Burger M; Wieland WF; Rößler W; Denzinger S
    Aktuelle Urol; 2012 May; 43(3):162-6. PubMed ID: 22639025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil.
    Rios LA; Averbeck MA; Franca W; Sacomani CA; Almeida FG; Gomes CM
    Int Braz J Urol; 2016; 42(2):312-20. PubMed ID: 27176186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.